RESEARCH-USE BIOSIMILAR ANTIBODY
Cosfroviximab
Monoclonal antibody · IgG1
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP).
TARGETZaire Ebolavirus GP
YMonoclonal antibody
CATALOGSC-BS-659
CATALOG NUMBERSC-BS-659
MOLECULAR WEIGHTApprox. 145.34 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP).
Cosfroviximab is a recombinant research-use antibody directed against Zaire Ebolavirus GP.